Which medications in the drug class Growth hormone releasing factor are used in the treatment of HIV Infection and AIDS?

Updated: Jul 27, 2020
  • Author: Shelley A Gilroy, MD, FACP, FIDSA; Chief Editor: Michael Stuart Bronze, MD  more...
  • Print

Growth hormone releasing factor

This agent decreases visceral adipose tissue.

Tesamorelin (Egrifta)

Tesamorelin is a growth hormone–releasing factor (GRF) analog indicated for reduction of excess abdominal fat in patients with HIV-associated lipodystrophy. This agent stimulates growth hormone production and increases serum levels of insulin-like growth factor–1 (IGF-1). It elicits anabolic and lipolytic actions.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!